Skip to main navigation Skip to search Skip to main content

Neuropeptides and pharmacology

  • Tamas Bartfai
  • , Pēteris Alberts
  • Stockholm University

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of the article is to briefly describe our work together with Dr. Viktor Mutt. He discovered and purified many new gastrointestinal bioactive neuropeptides that have important applications as therapeutic agents in diabetes, epilepsy, migraine and weight control. Dr. Mutt’s strategy was to search for C­terminally amidated peptides. We determined neuropeptide Y equilibrium binding for its receptor. Our work also included the L­Ala scan of pharmacophores of the neuropeptide galanin (1­28). Finally, the work led to the establishment of the coexistence of peptides with small molecule neurotransmitters, such as serotonin, acetylcholine, noradrenaline and dopamine in central and peripheral neurons.

Original languageEnglish
Pages (from-to)197-202
JournalProceedings of the Estonian Academy of Sciences
Volume73
Issue number3
DOIs
Publication statusPublished - 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • neuropeptides
  • neuropharmacology
  • transmitter coexistence

OECD Field of Science

  • 3. Medical and Health Sciences

Fingerprint

Dive into the research topics of 'Neuropeptides and pharmacology'. Together they form a unique fingerprint.

Cite this